Trained immunity – a process being explored in vaccine and therapy development to boost immune defences – appears be counterproductive in certain contexts, researchers at McGill University and the Research Institute of the McGill University Health Centre (The Institute) have found.

Trained immunity is when the body’s first line of defence remembers past threats and becomes more reactive, responding more strongly to future infections even if they are different, by changing how immune cells behave.

Classified as: Maziar Divangahi, Faculty of Medicine and Health Sciences, Research Institute of the McGill University Health Centre, Department of Medicine, lungs, vaccine development
Category:
Published on: 10 Jul 2025

First study of humans with a rare immunodeficiency reveals how the immune system protects the body against pathogens known to cause serious diseases, such as tuberculosis and COVID-19. The research involving McGill University, paves the way for new therapies to treat autoimmune diseases, chronic inflammatory diseases, and new approaches to vaccine development.

Classified as: immune system, covid-19, Immunodeficiency, tuberculosis, autoimmune diseases, chronic inflammatory disease, vaccine development
Published on: 8 May 2023
Back to top